Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
Metrics to compare | 2297 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2297PeersSector | |
---|---|---|---|---|
P/E Ratio | −2.3x | −22.3x | −0.5x | |
PEG Ratio | −1.12 | 0.14 | 0.00 | |
Price/Book | 0.6x | 1.7x | 2.6x | |
Price / LTM Sales | 6.4x | 4.5x | 3.1x | |
Upside (Analyst Target) | - | 29.7% | 47.8% | |
Fair Value Upside | Unlock | 9.5% | 6.9% | Unlock |